Nalaganje...
Immune Checkpoint Inhibitors to Treat Malignant Lymphomas
Genetic and/or epigenetic changes provide antigen-derived diversity in neoplastic cells. Beside, these cells do not initiate immune response of host organisms. A variety of factors are responsible for the resistant to treatment, including individual variations in patients and somatic cell genetic di...
Shranjeno v:
| izdano v: | J Immunol Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5925139/ https://ncbi.nlm.nih.gov/pubmed/29850620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/1982423 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|